ECO Animal Health Group plc (AIM:EAH)
London · Delayed Price · Currency is GBP · Price in GBX 108.50
-1.50 (-1.36%)
At close: Dec 5, 2025
ECO Animal Health Group Revenue
ECO Animal Health Group had revenue of 39.40M GBP in the half year ending September 30, 2025, with 3.66% growth. This brings the company's revenue in the last twelve months to 85.81M, up 1.44% year-over-year. In the fiscal year ending March 31, 2025, ECO Animal Health Group had annual revenue of 79.60M, down -10.99%.
Revenue (ttm)
85.81M
Revenue Growth
+1.44%
P/S Ratio
0.86
Revenue / Employee
429.07K
Employees
224
Market Cap
73.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 79.60M | -9.83M | -10.99% |
| Mar 31, 2024 | 89.42M | 4.11M | 4.82% |
| Mar 31, 2023 | 85.31M | 3.12M | 3.79% |
| Mar 31, 2022 | 82.20M | -23.41M | -22.17% |
| Mar 31, 2021 | 105.61M | 33.50M | 46.46% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
ECO Animal Health Group News
- 26 days ago - ECO Animal Health Receives Positive Opinion From CVMP For ECOVAXXIN MS - Nasdaq
- 5 months ago - AIM Market Roundup: Oxford Biodynamics, GCM Resources, ECO Animal Health - The Armchair Trader